Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.1 USD | +4.01% | +11.81% | -22.92% |
Financials (USD)
Sales 2024 * | 26.32M | Sales 2025 * | 155M | Capitalization | 2.1B |
---|---|---|---|---|---|
Net income 2024 * | -260M | Net income 2025 * | -219M | EV / Sales 2024 * | 72.3 x |
Net cash position 2024 * | 193M | Net cash position 2025 * | 111M | EV / Sales 2025 * | 12.8 x |
P/E ratio 2024 * |
-8.53
x | P/E ratio 2025 * |
-10.5
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.58% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | +4.01% | ||
1 week | +11.81% | ||
Current month | +8.35% | ||
1 month | -1.58% | ||
3 months | -16.15% | ||
6 months | -8.73% | ||
Current year | -22.92% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 45 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 23.1 | +3.91% | 553,782 |
24-06-04 | 22.23 | +1.37% | 523,597 |
24-06-03 | 21.93 | +2.86% | 654,963 |
24-05-31 | 21.32 | -0.61% | 554,881 |
24-05-30 | 21.45 | +3.82% | 683,734 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.92% | 2.1B | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.89% | 22.67B | |
-9.79% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- RCKT Stock